Zijuan Wu
Zijuan Wu
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
2
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
3
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
1,2,3,
Wei Zhang
Wei Zhang
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
4
Department of Hematology, Suqian Hospital, Jiangsu Province Hospital, Suqian, China
1,4,
Luqiao Wang
Luqiao Wang
5
Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
5,
Jiayan Leng
Jiayan Leng
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
6
Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China
1,6,
Yongle Li
Yongle Li
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
2
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
3
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
1,2,3,
Zhou Fan
Zhou Fan
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
1,
Mengtao Zhan
Mengtao Zhan
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
1,
Lei Cao
Lei Cao
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
2
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
3
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
1,2,3,
Yongning Jiang
Yongning Jiang
7
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
7,
Yan Jiang
Yan Jiang
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
1,
Bing Sun
Bing Sun
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
1,
Jianxin Fu
Jianxin Fu
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
8
The Central Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China
1,8,✉,
Jianyong Li
Jianyong Li
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
2
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
3
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
1,2,3,✉,
Wenyu Shi
Wenyu Shi
7
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
7,✉,
Hui Jin
Hui Jin
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
2
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
3
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
1,2,3,✉
1
Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China
2
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China
3
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China
4
Department of Hematology, Suqian Hospital, Jiangsu Province Hospital, Suqian, China
5
Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
6
Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China
7
Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
8
The Central Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China
*
Correspondence
, Hui Jin, Jianxin Fu and Jianyong Li Lymphoma Center, Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China. Email: jinzi817@live.cn, fujianxin2021@suda.edu.cn and lijianyonglm@126.com
, Wenyu Shi, Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China. Email: shiwenyu@hotmail.com
Received 2025 Mar 20; Accepted 2025 Mar 27; Collection date 2025 Apr.
© 2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.